EXAS Stock Soars on Abbott Takeover Talks: Exact Sciences Jumps Over 20% on November 19, 2025
Exact Sciences Corporation (NASDAQ: EXAS) is surging today after reports that healthcare giant Abbott Laboratories is in advanced talks to acquire the cancer diagnostics specialist. Shares of EXAS spiked sharply intraday, briefly approaching new 52‑week highs as traders rushed into the name on renewed takeover speculation. Reuters+2Investing.com+2 Key points EXAS stock today: price, move, and trading activity According to Exact Sciences’ own investor relations quote page, EXAS was recently quoted at $81.79, up $12.11 or +17.38% versus yesterday’s close at $69.68. Intraday, the stock has traded between $69.11 and $89.67, with volume already above 10.4 million shares, far exceeding its recent averages. investor.exactsciences.com+1 Other real‑time feeds and
